Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Injectable agents: present and future.

Deborah J Lightner1, Nancy B Itano, Susan D Sweat

  • 1Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. lightner.deborah@mayo.edu

Current Urology Reports
|October 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urologist's Fatigue and Discomfort in Different Body Regions After Performing Flexible Ureteroscopy.

Urology·2025
Same author

Musculoskeletal Disorders Among Surgeons and Attitudes Towards Wearable Devices for Ergonomic Optimization.

Annals of surgery·2024
Same author

The Retrospective Stressor Analysis (RSA): a novel qualitative tool for identifying causes of burnout and mitigation strategies during residency.

BMC medical education·2024
Same author

Presbyopia in Surgeons: Ergonomic Impact and Tips for Management.

Annals of surgery·2024
Same author

Optimizing ergonomics during open, laparoscopic, and robotic-assisted surgery: A review of surgical ergonomics literature and development of educational illustrations.

American journal of surgery·2023
Same author

Examining the surgical stress effects (SSE) framework in practice: A qualitative assessment of perceived sources and consequences of intraoperative stress in surgical teams.

American journal of surgery·2023
Same journal

Single Port Robotic Surgery in Benign Urologic Disease - A Review of Contemporary Applications and Outcomes.

Current urology reports·2026
Same journal

Effective Mentorship in Urology Fellowship Training: Qualities, Models, and Equity.

Current urology reports·2026
Same journal

Management of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis.

Current urology reports·2026
Same journal

Lower Urinary Tract Symptoms as an Indicator of Occult Neurologic Disease: A System-first Framework for Urologic Practice.

Current urology reports·2026
Same journal

Association Between Ambient Temperature and Urolithiasis: A Systematic Review and Meta-analysis.

Current urology reports·2026
Same journal

Is Open Partial Nephrectomy Still an Option in the Robotic Era?

Current urology reports·2026
See all related articles

Minimally invasive bulking agents offer a safe and effective treatment for stress urinary incontinence (SUI) when conservative methods fail. Newer agents show promise for long-term durability and improved therapeutic options for women with SUI.

Area of Science:

  • Urology
  • Gynecology
  • Biomaterials Science

Background:

  • Stress urinary incontinence (SUI) is a prevalent condition often managed conservatively.
  • Failure of conservative strategies necessitates exploring effective, safe, and durable minimally invasive treatments.
  • Current treatments aim to reduce medical costs associated with SUI management.

Purpose of the Study:

  • To review current basic science and clinical research on newer agents for soft-tissue bulking in SUI treatment.
  • To evaluate the efficacy and durability of existing and emerging bulking agents.
  • To explore new therapeutic options for women suffering from SUI.

Main Methods:

  • Review of existing literature on bulking agents for SUI.
  • Analysis of basic science research on material development.

Related Experiment Videos

  • Evaluation of clinical data on efficacy and safety of minimally invasive SUI treatments.

    • Main Results:

    • Injection of available bulking agents is a safe, minimally invasive procedure with demonstrated efficacy.
    • Success rates for bulking agents in anatomic SUI are comparable to those in intrinsic sphincter deficiency.
    • Long-term durability of several current agents requires further investigation.

    Conclusions:

    • Minimally invasive bulking agents represent a viable treatment option for SUI.
    • Further research is needed to establish the long-term durability of newer agents.
    • Bulking agents offer expanded therapeutic possibilities for women with SUI.